Skip to main content
. 2024 Mar 26;60(4):539. doi: 10.3390/medicina60040539

Figure 1.

Figure 1

In vivo study design and schedule for DSS-administration and intraperitoneal injection of anti-ORAIP mAb and control mouse IgG.